MeasurementMedia in Industry & ScienceNewsMolecules, Vol. 22, Pages 1950: NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Comments are closed.

Do NOT follow this link or you will be banned from the site!